EUVIMEDEUVIMED entdecken
Systematische ÜbersichtUmbrella ReviewOpen Access · CC BY 4.0

Cognitive impairment following breast cancer treatments: an umbrella review

Giulia Oliva iD, Andreina Giustiniani, Laura Danesin, Francesca Burgio, Giorgio Arcara, Pierfranco Conte

The Oncologist · 05.07.2024 · 29 (7) · e848-e863

DOI: 10.1093/oncolo/oyae090 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift The Oncologist, online erschienen am 09.05.2024. Verfasst von Giulia Oliva und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Oncology and Gastroenterology (DiSCOG), University of Padua, 35124 Padova, Italy. Hauptthemen laut MEDLINE: Breast Neoplasms, Cognitive Dysfunction. Die Arbeit wurde bisher 82-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Cancer-related cognitive impairment (CRCI) refers to a cognitive decline associated with cancer or its treatments. While research into CRCI is expanding, evidence remains scattered due to differences in study designs, methodologies, and definitions. The present umbrella review aims to provide a comprehensive overview of the current evidence regarding the impact of different breast cancer therapies on cognitive functioning, with a particular focus on the interplay among objective cognitive deficits (ie, measured with standardized tests), subjective cognitive concerns, (ie, self-reported), and other mediating psycho-physical factors.

Methods

The search was made in Pubmed, Embase, and Scopus for articles published until July 2023, following the guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-analysis protocol.

Results

Chemotherapy and endocrine therapy appear consistently associated with CRCI in patients with breast cancer, primarily affecting memory, attention/concentration, executive functioning, and processing speed. Subjective cognitive concerns were often found weakly or not associated with neuropsychological test results, while overall CRCI seemed consistently associated with psychological distress, fatigue, sleep quality, and inflammatory and biological factors.

Conclusion

Current evidence suggests that CRCI is common after chemotherapy and endocrine therapy for breast cancer. However, heterogeneity in study designs and the scarcity of studies on more recent treatments such as targeted therapies and immunotherapies, highlight the need for more systematic and harmonized studies, possibly taking into account the complex and multifactorial etiology of CRCI. This may provide valuable insights into CRCI’s underlying mechanisms and potential new ways to treat it.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsCognitive DysfunctionHumansFemale

Stichwörter der Autor:innen

breast cancercancer treatmentscognitive impairmentobjective cognitive deficitsquality of lifesubjective cognitive concerns

Autor:innen und Institutionen

  • Department of Surgery, Oncology and Gastroenterology (DiSCOG), University of Padua, 35124 Padova, Italy.
  • IRCCS San Camillo Hospital, 30126 Venice, Italy.

ORCID-Profile: Giulia Oliva

Zitieren

APA

Oliva, G., Giustiniani, A., Danesin, L., Burgio, F., Arcara, G., & Conte, P. (2024). Cognitive impairment following breast cancer treatments: an umbrella review. The Oncologist, 29(7), e848-e863. https://doi.org/10.1093/oncolo/oyae090

Vancouver

Oliva G, Giustiniani A, Danesin L, Burgio F, Arcara G, Conte P. Cognitive impairment following breast cancer treatments: an umbrella review. The Oncologist. 2024;29(7):e848-e863. doi:10.1093/oncolo/oyae090

BibTeX
@article{Oliva2024,
  author = {Oliva, Giulia and Giustiniani, Andreina and Danesin, Laura and Burgio, Francesca and Arcara, Giorgio and Conte, Pierfranco},
  title = {Cognitive impairment following breast cancer treatments: an umbrella review},
  journal = {The Oncologist},
  year = {2024},
  volume = {29},
  number = {7},
  pages = {e848--e863},
  doi = {10.1093/oncolo/oyae090}
}
Kostenlos starten →